Adenocarcinoma of the prostate with atrophic features

被引:44
作者
Cina, SJ [1 ]
Epstein, JI [1 ]
机构
[1] JOHNS HOPKINS UNIV,INST MED,DEPT PATHOL,BALTIMORE,MD
关键词
atrophy; prostatic adenocarcinoma; prostate;
D O I
10.1097/00000478-199703000-00004
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Adenocarcinomas of the prostate with attenuated cytoplasm (i.e., atrophic features) have not been studied formally and represent a diagnostic dilemma to the surgical pathologist. Forty-four cases of adenocarcinoma with atrophic features seen at the Johns Hopkins Medical Institutions were reviewed. Forty-two cases were seen on needle biopsy, and two were from transurethral resection specimens. Neoplastic atrophic glands were characterized by cells with a paucity of cytoplasm, such that the nuclei occupied pied almost the entire cell height. Atrophic cancers were defined as cancers with atrophic glands constituting greater than or equal to 50% of the tumor. Ony two of 44 patients whose prostatic adenocarcinoma showed atrophic features were on hormone therapy at the time of biopsy. Forty-one cases had an infiltrative pattern of growth. Thirty-nine cases were Gleason grade 3 + 3 = 6. Nuclear size was increased in 39 cases, and macronucleoli were noted in 21 cases. The most useful criteria to establish a diagnosis of adenocarcinoma were (1) an infiltrative pattern of growth, (2) the presence of macronucleoli, (3) increased nuclear size, and (4) the presence of adjacent, nonatrophic cancer.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 18 条
[1]   CLINICAL AND PATHOBIOLOGICAL EFFECTS OF NEOADJUVANT TOTAL ANDROGEN ABLATION THERAPY ON CLINICALLY LOCALIZED PROSTATIC ADENOCARCINOMA [J].
ARMAS, OA ;
APRIKIAN, AG ;
MELAMED, J ;
CORDONCARDO, C ;
COHEN, DW ;
ERLANDSON, R ;
FAIR, WR ;
REUTER, VE .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (10) :979-991
[2]  
BRAWER MK, 1985, CANCER RES, V45, P3663
[3]   POSTATROPHIC HYPERPLASIA OF THE PROSTATE - A HISTOLOGIC MIMIC OF PROSTATIC ADENOCARCINOMA [J].
CHEVILLE, JC ;
BOSTWICK, DG .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (09) :1068-1076
[4]  
Civantos F, 1996, Semin Urol Oncol, V14, P22
[5]   DIAGNOSTIC-CRITERIA OF LIMITED ADENOCARCINOMA OF THE PROSTATE ON NEEDLE-BIOPSY [J].
EPSTEIN, JI .
HUMAN PATHOLOGY, 1995, 26 (02) :223-229
[6]  
EPSTEIN JI, 1992, DIFFERENTIAL DIAGNOS, P84
[7]  
EPSTEIN JI, 1996, INTERPRETATION PROST, P165
[8]   USE OF KERATIN 903 AS AN ADJUNCT IN THE DIAGNOSIS OF PROSTATE CARCINOMA [J].
HEDRICK, L ;
EPSTEIN, JI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1989, 13 (05) :389-396
[9]   UTILIZATION OF HIGH-MOLECULAR-WEIGHT CYTOKERATIN ON PROSTATE NEEDLE BIOPSIES IN AN INDEPENDENT LABORATORY [J].
KAHANE, H ;
SHARP, JW ;
SHUMAN, GB ;
DASILVA, G ;
EPSTEIN, JI .
UROLOGY, 1995, 45 (06) :981-986
[10]  
MURPHY WM, 1991, CANCER, V68, P821, DOI 10.1002/1097-0142(19910815)68:4<821::AID-CNCR2820680426>3.0.CO